DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Finn RS, Qin S, Ikeda M. et al.
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
N Engl J Med 2020;
382: 1894-1905
We do not assume any responsibility for the contents of the web pages of other providers.